Cargando…

Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future

Tyrosine-protein phosphatase non-receptor type 2(PTPN2), an important member of the protein tyrosine phosphatase family, can regulate various signaling pathways and biological processes by dephosphorylating receptor protein tyrosine kinases. Accumulating evidence has demonstrated that PTPN2 is invol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Xiao-Er, Cheng, Ya-Qiong, Tang, Chao-Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475599/ https://www.ncbi.nlm.nih.gov/pubmed/37670950 http://dx.doi.org/10.3389/fphar.2023.1219690

Ejemplares similares

Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future
por: Alam, Manzar, et al.
Publicado: (2022)

The Anti-allergic Cromones: Past, Present, and Future
por: Sinniah, Ajantha, et al.
Publicado: (2017)

Verapamil and Alzheimer’s Disease: Past, Present, and Future
por: Popović, Natalija, et al.
Publicado: (2020)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
por: Sudhesh Dev, Sareshma, et al.
Publicado: (2021)

Metabolic Studies in Brain Slices – Past, Present, and Future
por: Hertz, Leif
Publicado: (2012)

The South African Regulatory System: Past, Present, and Future
por: Keyter, Andrea, et al.
Publicado: (2018)

Evaluation of the Hypoglycemic Activity of Morchella conica by Targeting Protein Tyrosine Phosphatase 1B
por: Begum, Naeema, et al.
Publicado: (2021)

Review of Urate-Lowering Therapeutics: From the Past to the Future
por: Jenkins, Christopher, et al.
Publicado: (2022)

Voltage sensitive phosphatases: emerging kinship to protein tyrosine phosphatases from structure-function research
por: Hobiger, Kirstin, et al.
Publicado: (2015)

Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A(2A) Receptor-Mediated Effects in the Central Nervous System
por: Domenici, Maria Rosaria, et al.
Publicado: (2021)

Targeting angiogenesis for liver cancer: Past, present, and future
por: Zhu, Xiao-Dong, et al.
Publicado: (2020)

Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
por: Pardella, Elisa, et al.
Publicado: (2020)

Therapeutic Targeting of Protein Tyrosine Phosphatases from Mycobacterium tuberculosis
por: Ruddraraju, Kasi Viswanatharaju, et al.
Publicado: (2020)

Modeling Alzheimer’s disease: from past to future
por: Saraceno, Claudia, et al.
Publicado: (2013)

Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients
por: Ismail, Mohamed A., et al.
Publicado: (2022)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
por: Zhang, Li, et al.
Publicado: (2020)

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance
por: Dong, Hongmei, et al.
Publicado: (2022)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
por: Corti, Alessandro, et al.
Publicado: (2020)

Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases
por: Li, Jiadong, et al.
Publicado: (2022)

Herpesvirus BACs: Past, Present, and Future
por: Warden, Charles, et al.
Publicado: (2011)

Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease
por: Pastore, Mirella, et al.
Publicado: (2019)

Past, Present and Future Therapeutics for Cerebellar Ataxias
por: Marmolino, D, et al.
Publicado: (2010)

Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2021)

Angioplasty, Stenting and Other Potential Treatments of Atherosclerotic Stenosis of the Intracranial Arteries: Past, Present and Future
por: Wabnitz, Ashley, et al.
Publicado: (2017)

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

CMOS: past, present and future
por: Radamson, Henry, et al.
Publicado: (2018)

Corrigendum to “Herpesvirus BACs: Past, Present, and Future”
por: Warden, Charles, et al.
Publicado: (2019)

Iron Therapeutics in Women’s Health: Past, Present, and Future
por: Mintz, Joel, et al.
Publicado: (2020)

Therapeutic management of hereditary angioedema: past, present, and future
por: Valerieva, Anna, et al.
Publicado: (2021)

Targeting Oncogenic BRAF: Past, Present, and Future
por: Zaman, Aubhishek, et al.
Publicado: (2019)

Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
por: Hümmeke-Oppers, Femke, et al.
Publicado: (2019)

Receptor-type protein tyrosine phosphatases in cancer
por: Du, Yu, et al.
Publicado: (2015)

Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases
por: Li, Hui, et al.
Publicado: (2021)

Targeting Protein-Tyrosine Phosphatases in Breast Cancer
por: Aceto, Nicola, et al.
Publicado: (2012)

Crab cavities for colliders: past, present and future
por: Verdú-Andrés, Silvia, et al.
Publicado: (2016)

Therapeutic strategies for anchored kinases and phosphatases: exploiting short linear motifs and intrinsic disorder
por: Nygren, Patrick J., et al.
Publicado: (2015)

Past, present and future
Publicado: (1982)

Past, present and future
Publicado: (2000)

Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
por: Yao, Jiaqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_64g81ut0cl1lage22j32879nsf